Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RECCE PHARMACEUTICALS LTD Capital/Financing Update 2024

Aug 5, 2024

65669_rns_2024-08-05_c20f2521-086c-4b33-81fa-6442127a09c3.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Announcement Summary

Entity name

RECCE PHARMACEUTICALS LTD

Announcement Type

New announcement

Date of this announcement

Tuesday August 06, 2024

The +securities to be quoted are:

Total number of +securities to be quoted +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

ASX +securitycode Security description Number of +securities tobe quoted Issue date
RCE ORDINARY FULLY PAID 9,844,296 06/08/2024

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

1.1 Name of entity

RECCE PHARMACEUTICALS LTD

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ACN

Registration number

124849065

1.3 ASX issuer code

RCE

1.4 The announcement is 1.5 Date of this announcement New announcement

6/8/2024

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Previous Appendix 3B details:
Announcement Date andTime Announcement Title Selected Appendix 3B to submit quotationrequest
02-Jul-2024 10:23 New - Proposed issue of securities -RCE An offer of +securities under a +securitiespurchase plan

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

No

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Corporate Action Component Detail

ASX +security code and description

RCE : ORDINARY FULLY PAID

Issue date

6/8/2024

Distribution Schedule

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

Number of +securities held Number of holders Total percentage of +securities heldFor example, to enter a value of 50%please input as 50.00
1 - 1,000 %
1,001 - 5,000 %
5,001 - 10,000 %
10,001 - 100,000 %
100,001 and over %

Issue details

Number of +securities to be quoted 9,844,296 Issue currency AUD - Australian Dollar Issue price or consideration per +security AUD 0.45000000

Any other information the entity wishes to provide about the +securities to be quoted

The SPP closed oversubscribed, the initial target raise being $2 million. In accordance with the terms of the SPP, the Board exercised its discretion and determined to accept all valid applications in full to raise $4.4 million under the SPP.

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity willcomprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital ifother Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the+securities subject of this application)
ASX +security code and description Total number of+securities on issue
RCE : ORDINARY FULLY PAID 231,609,328
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of+securities on issue
RCEAH : PERFORMANCE SHARES 8,754,423
RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56 435,000
RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 1,125,000
RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56 8,415,000